These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 18710984

  • 1. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
    Okuda S, Oshio K, Shinmoto H, Tanimoto A, Asada H, Fujii T, Yoshimura Y, Kuribayashi S.
    Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
    [Abstract] [Full Text] [Related]

  • 2. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ, Suo ST, Zhang XB, Zhong YC, Zhuang ZG, Cheng JJ, Chi JC, Xu JR.
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [Abstract] [Full Text] [Related]

  • 3. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
    Hori M, Kim T, Onishi H, Ueguchi T, Tatsumi M, Nakamoto A, Tsuboyama T, Tomoda K, Tomiyama N.
    Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
    [Abstract] [Full Text] [Related]

  • 4. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists.
    Nagai K, Asano R, Sekiguchi F, Asai-Sato M, Miyagi Y, Miyagi E.
    Am J Obstet Gynecol; 2023 Feb; 228(2):207.e1-207.e9. PubMed ID: 36150519
    [Abstract] [Full Text] [Related]

  • 5. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
    Broekmans FJ, Heitbrink MA, Hompes PG, Schoute E, Falke T, Schoemaker J.
    Magn Reson Imaging; 1996 Feb; 14(10):1127-35. PubMed ID: 9065902
    [Abstract] [Full Text] [Related]

  • 6. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S, Orio F, Russo T, Falbo A, Cascella T, Doldo P, Nappi C, Lombardi G, Mastrantonio P, Zullo F.
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [Abstract] [Full Text] [Related]

  • 7. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
    Okuda S, Oshio K, Asada H, Tanimoto A, Jinzaki M, Furuya M, Yoshimura Y, Kuribayashi S.
    Magn Reson Med Sci; 2012 Jun; 11(4):283-9. PubMed ID: 23269015
    [Abstract] [Full Text] [Related]

  • 8. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K, Kawamura N, Ishiko O, Ogita S.
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [Abstract] [Full Text] [Related]

  • 9. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
    Matsuno Y, Yamashita Y, Takahashi M, Katabuchi H, Okamura H, Kitano Y, Shimamura T.
    Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
    [Abstract] [Full Text] [Related]

  • 10. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
    Yamashita Y, Torashima M, Takahashi M, Tanaka N, Katabuchi H, Miyazaki K, Ito M, Okamura H.
    Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
    [Abstract] [Full Text] [Related]

  • 11. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH, Lee WL, Cheng MH, Yen MS, Chao KC, Chao HT.
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [Abstract] [Full Text] [Related]

  • 12. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG, Vercellini P, Meschìa M, Oldani S, Bramante T.
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [Abstract] [Full Text] [Related]

  • 13. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
    Zawin M, McCarthy S, Scoutt L, Lange R, Lavy G, Vulte J, Comite F.
    Radiology; 1990 May; 175(2):503-6. PubMed ID: 2109336
    [Abstract] [Full Text] [Related]

  • 14. Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization.
    Lee MS, Kim MD, Jung DC, Lee M, Won JY, Park SI, Lee DY, Lee KH.
    J Vasc Interv Radiol; 2013 Sep; 24(9):1361-5. PubMed ID: 23891046
    [Abstract] [Full Text] [Related]

  • 15. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC, Wu TI, Wang CC, Chen YR, Huang YT, Ng SH, Jung SM, Chang TC, Lai CH.
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.